Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gwt-tud Gmbh

Clinical trials sponsored by Gwt-tud Gmbh, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug may cut transfusions for MDS patients Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 3

New drug may cut transfusions for MDS patients

Disease control Ongoing

This study tests a drug called luspatercept in 70 adults with a low-risk form of MDS that causes anemia. The goal is to see if the drug can reduce the need for red blood cell transfusions. Participants receive the drug and are monitored for safety and effectiveness over time.

Phase 3 • Sponsor: GWT-TUD GmbH • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC